Venus Remedies Share Price

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Venus Remedies announced Q2FY27 results</strong></span><br /> <!--TgQPHd|||[[2,[null,null,null,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></h3> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAICRAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="RdhNte_1j"> <li data-complete="true" data-hveid="CAAICRAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_1k"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_1m">Revenue from operations<!--TgQPHd|||[]--></strong> was Rs 218.76 crore in Q2FY27, up by 22.31% QoQ compared to Rs 178.86 crore in Q1FY27 and up by 13.43% YoY from Rs 192.75 crore in Q2FY25. For H1FY27, consolidated revenue from operations reached Rs 397.62 crore, showing a YoY growth of 20.52% from Rs 329.93 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_1s"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_1u">Total income<!--TgQPHd|||[]--></strong> stood at Rs 219.27 crore in Q2FY27, showing a sequential growth of 20.82% QoQ against Rs 181.48 crore in Q1FY27 and an expansion of 12.76% YoY against Rs 194.46 crore in Q2FY25. For H1FY27, total income recorded was Rs 400.75 crore, up by 19.61% YoY over Rs 335.05 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_20"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_22">Profit before tax (PBT)<!--TgQPHd|||[]--></strong> stood at Rs 33.47 crore in Q2FY27, increasing by 11.42% QoQ compared to Rs 30.04 crore in Q1FY27 and growing by 26.35% YoY from Rs 26.49 crore in Q2FY25. For H1FY27, PBT reached Rs 63.51 crore, showing a YoY increase of 62.47% from Rs 39.09 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_28"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_2a">Profit after tax (PAT)<!--TgQPHd|||[]--></strong> was Rs 25.65 crore in Q2FY27, growing by 11.67% sequentially against Rs 22.97 crore in Q1FY27 and growing by 27.42% YoY from Rs 20.13 crore in Q2FY25. For H1FY27, consolidated PAT stood at Rs 48.62 crore, translating to a YoY increase of 63.54% compared to Rs 29.73 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_2g"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_2i">Earnings per share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted stood at Rs 19.19 in Q2FY27, up by 11.70% sequentially against Rs 17.18 in Q1FY27 and higher by 27.42% YoY compared to Rs 15.06 in Q2FY25. For H1FY27, basic and diluted EPS reached Rs 36.37, expanding by 63.53% YoY against Rs 22.24 in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAICxAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="RdhNte_33"> <li data-complete="true" data-hveid="CAAICxAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_34"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_36">Revenue from operations<!--TgQPHd|||[]--></strong> reached Rs 218.76 crore in Q2FY27, scaling up by 22.35% QoQ from Rs 178.80 crore in Q1FY27 and increasing by 13.55% YoY compared to Rs 192.65 crore in Q2FY25. For H1FY27, standalone revenue from operations stood at Rs 397.55 crore, increasing by 20.55% YoY over Rs 329.78 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_37"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_39">Total income<!--TgQPHd|||[]--></strong> stood at Rs 219.16 crore in Q2FY27, up by 20.85% sequentially QoQ against Rs 181.35 crore in Q1FY27 and increasing by 12.78% YoY from Rs 194.33 crore in Q2FY25. For H1FY27, standalone total income reached Rs 400.50 crore, expanding by 19.85% YoY compared to Rs 334.18 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_3a"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_3c">Profit before tax (PBT)<!--TgQPHd|||[]--></strong> was Rs 36.77 crore in Q2FY27, up by 12.76% QoQ from Rs 32.61 crore in Q1FY27 and growing by 43.63% YoY from Rs 25.60 crore in Q2FY25. For H1FY27, PBT stood at Rs 69.35 crore, recording a YoY expansion of 72.04% over Rs 40.31 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_3d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_3f">Profit after tax (PAT)<!--TgQPHd|||[]--></strong> stood at Rs 28.96 crore in Q2FY27, demonstrating a QoQ increase of 13.43% against Rs 25.53 crore in Q1FY27 and a YoY expansion of 50.52% from Rs 19.24 crore in Q2FY25. For H1FY27, standalone PAT reached Rs 54.46 crore, recording a 75.96% YoY growth against Rs 30.95 crore in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RdhNte_3g"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RdhNte_3i">Earnings per share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted was Rs 21.66 in Q2FY27, displaying a sequential expansion of 13.40% QoQ over Rs 19.10 in Q1FY27 and increasing by 50.42% YoY against Rs 14.40 in Q2FY25. H1FY27 basic and diluted EPS reached Rs 40.74, up 75.98% YoY compared to Rs 23.15 in H1FY25.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> </ul> <p><a class="lb" href="/get-document/post/pdf/5910990/" target="_blank">Result PDF</a></p>

• Trendlyne
• 19 hours 33 minutes ago

As per the file enclosed.

• BSE India
• 1 day 13 hours ago

Outcome of Board Meeting date 26th October 2026 and Unaudited Financial Results for the period ended on 30th September 2026.

• BSE India
• 1 day 13 hours ago